Jean-Mathieu Beauregard

Associate Professor

Laval University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Medical Imaging Medical Imaging professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jean-Mathieu Beauregard is an Associate Professor at Université Laval in Canada. His research focuses on optimizing therapies for neuroendocrine tumors, including the use of PARP inhibitors and peptide receptor radionuclide therapy. Recent publications highlight his work on dosimetry, SPECT/CT calibration, and the implications of GLUT1 expression in high-risk prostate cancer.

Articles (6)

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Girish Shah

Laval University

CANADA

View details

Philippe Després

Institut universitaire de cardiologie et de pneumologie de Québec

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Mathieu Beauregard

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Optimizing the Schedule of PARP Inhibitors in Combination with <sup>177</sup>Lu-DOTATATE: A Dosimetry Rationale

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells

Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction

GLUT1 expression in high-risk prostate cancer: correlation with <sup>18</sup>F-FDG-PET/CT and clinical outcome

Impact of dead time on quantitative <sup>177</sup>Lu-SPECT (QSPECT) and kidney dosimetry during PRRT

Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours

Collaborators (2)

Girish Shah

Philippe Després

Make your next move.